Individuals with Behçet's disease suffer from episodic inflammation often affecting the orogenital mucosa, skin and eyes. To discover new susceptibility loci for Behçet's disease, we performed a genome-wide association study (GWAS) of 779,465 SNPs with imputed genotypes in 1,209 Turkish individuals with Behçet's disease and 1,278 controls. We identified new associations at CCR1, STAT4 and KLRC4. Additionally, two SNPs in ERAP1, encoding ERAP1 p.Asp575Asn and p.Arg725Gln alterations, recessively conferred disease risk. These findings were replicated in 1,468 independent Turkish and/or 1,352 Japanese samples (combined meta-analysis P < 2 × 10 −9 ). We also found evidence for interaction between HLA-B*51 and ERAP1 (P = 9 × 10 −4 ). The CCR1 and STAT4 variants were associated with gene expression differences. Three risk loci shared with ankylosing spondylitis and psoriasis (the MHC class I region, ERAP1 and IL23R and the MHC class I-ERAP1 interaction), as well as two loci shared with inflammatory bowel disease (IL23R and IL10) implicate shared pathogenic pathways in the spondyloarthritides and Behçet's disease.
in these countries 2 . Genetic risk factors contribute to disease susceptibility. HLA-B*51 is the most strongly associated risk factor for Behçet's disease, which has been confirmed in multiple populations [3] [4] [5] . Although its association was established more than three decades ago, the role of HLA-B*51 in disease pathogenesis remains elusive 5 . In addition to HLA-B*51, two recent independent GWAS identified variants in regions encompassing the major histocompatibility complex (MHC) class I locus, IL10 and IL23R, that were associated with Behçet's disease in both the Turkish and Japanese populations 6, 7 . However, the combined effects of these genetic factors do not fully explain the observed disease heritability.
The pathobiology of Behçet's disease is also largely unknown. In 1974, on the basis of clinical features, Moll et al. proposed the concept of 'seronegative spondylarthritides' and included Behçet's disease along with ankylosing spondylitis, psoriatic arthritis, reactive arthritis and inflammatory bowel disease (IBD) 8 . Since then, the inclusion of Behçet's disease within the spondyloarthropathy category has been debated, as individuals with Behçet's disease rarely exhibit sacroiliitis, and Behçet's disease is associated with HLA-B*51 rather than HLA-B*27 (refs. 9-11) . In contrast, overlapping extra-articular clinical manifestations (inflammation in the eyes, skin and intestine), genetic associations at the MHC class I region and IL23R 6, 7, [12] [13] [14] , and the effectiveness of tumor necrosis factor (TNF)-α blockade 15, 16 suggest shared pathogenesis between Behçet's disease and other disorders classified as spondyloarthropathy diseases. Furthermore, IL10 and IL23R variants were found to be associated with both Behçet's disease and Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 l e t t e r s IBD (Crohn's disease and ulcerative colitis), implicating common inflammatory pathways in Behçet's disease and these other members of the spondyloarthropathy group 17, 18 .
To identify additional loci associated with Behçet's disease, we imputed the genotypes of autosomal SNPs in our GWAS collection of 1,209 Behçet's disease cases and 1,278 controls, using previously genotyped SNPs 6 and a reference panel of 96 Turkish controls genotyped at 814,474 SNPs (Online Methods). After quality control filtering, 779,465 autosomal imputed SNPs were subjected to statistical analysis by basic allele test using the best-guess imputed genotypes. In addition to the previously reported MHC class I region, IL10 and IL23R discovery signals, we observed a strong signal in the CCR1-CCR3 locus encoding C-C chemokine receptors with a P value that reached genome-wide significance of P < 5 × 10 −8 (rs7616215, P = 1.29 × 10 −8 ; Fig. 1 ). Markers associated at P < 3 × 10 −5 are listed in Supplementary Table 1 .
We selected 21 SNPs from the new loci identified by imputation and 1 SNP from the previously reported Japanese GWAS 7 for genotyping in a Turkish replication collection comprising 838 Turkish Behçet's disease cases and 630 controls that were newly collected (Supplementary Table 2 ). Four promising loci, STAT4 (encoding signal transducer and activator of transcription 4), KLRC4 (encoding killer cell lectin-like receptor subfamily C, member 4), the CCR1-CCR3 locus and IL12A (encoding interleukin-12, α chain) were then selected for validation of the imputed data by direct genotyping and fine-mapping studies in the original Turkish GWAS samples. We found the strongest signals at rs7616215 3′ of CCR1, at rs7574070 in intron 3 of STAT4, and at nonsynonymous SNPs rs2617170 and rs1841958 encoding KLRC4 p.Asn104Ser and p.Ile129Ser alterations (Fig. 2a-c) . In a metaanalysis, we combined the Turkish GWAS and replication data and, if polymorphic, the Japanese replication data (from the reported GWAS collection with 612 cases and 740 controls 7 ) using CochranMantel-Haenszel tests ( Fig. 2 and Table 1 ). Three loci (CCR1-CCR3, STAT4 and KLRK1-KLRC1) were associated with Behçet's disease at genome-wide significance (P = 1.34 × 10 −9 to 4.30 × 10 −13 ). Additionally, the IL12A locus exhibited suggestive association (P = 6 × 10 −7 ). Of the 612 Japanese cases ascertained using the Japanese diagnostic criteria 7 , 496 also fulfilled the International Study Group Criteria 19 . An analysis including only cases that met the International Study Group criteria showed genome-wide significance for associations at the same three loci, despite the reduced numbers of samples (Supplementary Table 3) .
In an attempt to reduce genetic heterogeneity, we performed genome-wide association tests in the subset of GWAS discovery cases with uveitis (435 cases and 1,278 controls) 6 . Neither the basic allelic test nor the dominant model test showed associations outside of the MHC region. However, when we applied a recessive model, one SNP in the ERAP1-ERAP2 locus showed association with a P value close to the genome-wide significance level (rs2927615, P = 1.02 × 10 −7 ). We performed fine mapping of this region in the uveitis subset of the GWAS discovery collection and identified rs10050860 and rs17482078, encoding ERAP1 p.Asp575Asn and p.Arg725Gln alterations, which conferred risk for Behçet's disease with uveitis in a recessive model (Fig. 2d) . In a meta-analysis of the SNP encoding p.Arg725Gln combining the Turkish discovery and replication collections (790 Behçet's disease cases with uveitis and 1,879 controls), the association exceeded the three-model threshold for genome-wide significance, and there was a large effect size of the homozygous genotype encoding the p.Arg725Gln alteration on Behçet's disease with uveitis (odds ratio (OR) = 4.56, P = 4.73 × 10 −11 ; Fig. 2d and Table 1) .
Because a recessive model was required to detect the ERAP1 association in individuals with Behçet's disease who had uveitis, we tested whether the recessive model would detect the association of the ERAP1 p.Arg725Gln alteration with Behçet's disease susceptibility in the combined uveitis and non-uveitis samples. A meta-analysis of the GWAS and replication collections found significant association of the homozygous genotype encoding the p.Arg725Gln alteration with Behçet's disease susceptibility (P = 4.35 × 10 −8 ; Supplementary Table 4 ). The minor allele frequency of rs2927615 (a variant in strong linkage disequilibrium (LD) with the mutation encoding p.Arg725Gln) was too low in the Japanese population (1.8% in Behçet's disease cases and 2.0% in controls) to evaluate recessive effects. Furthermore, none of the Japanese GWAS SNPs from the regions encompassing ERAP1 and IL12A (rs17810546 was not polymorphic in the Japanese population) were associated with Behçet's disease (Supplementary Table 5 ).
ERAP1 is an endoplasmic reticulum-expressed aminopeptidase that functions to trim peptides for loading onto MHC class I molecules 20 . Previous GWAS have established associations with ERAP1 variants in psoriasis 21, 22 and ankylosing spondylitis 12 . The mutations encoding ERAP1 p.Asp575Asn and p.Arg725Gln, which are in strong LD, confer protection against these diseases through reduced peptide trimming and antigen presentation by MHC class I molecules 12, [22] [23] [24] . Of note, recent reports have shown that these ERAP1 variants confer protection preferentially in HLA-B*27-positive individuals in ankylosing spondylitis 23 and HLA-C*06-positive individuals in psoriasis 22 , suggesting that peptide processing and binding and/or presentation mechanisms contribute to the pathogenesis of these diseases.
We therefore tested for an interaction between HLA-B*51 and ERAP1 in Behçet's disease. The ERAP1 variants preferentially conferred risk for Behçet's disease in HLA-B*51-positive individuals (P value for interaction = 0.0009 from a logistic likelihood ratio test comparing the full model, including a multiplicative interaction term, with the reduced model without the interaction term) in the combined Turkish GWAS and replication (including uveitis and non-uveitis) samples (Fig. 3) . Furthermore, homozygosity for the mutation encoding ERAP1 p.Arg725Gln was associated with an OR for Behçet's disease of 3.78 (95% confidence interval (CI) = 1.94-7.35) in the Homozygosity for the ERAP1 variants is associated with increased risk for Behçet's disease but decreased risk for ankylosing spondylitis 23 and psoriasis 22 . The difference between risk and protection among these three diseases may depend on the variability and binding affinities of peptides loaded onto the respective MHC class I molecules, which can affect their stability and function. Indeed, the repertoires of MHC-bound peptides are altered in Erap1-deficient mice 25 . ERAP1 p.Arg725Gln-related alterations might affect the repertoire of peptides that bind to HLA-B*51, which is known for its promiscuous peptide-binding features 5, 26 . The recessive nature of the ERAP1 effect in Behçet's disease (one wild-type copy in heterozygotes is sufficient to obscure the risk effect of the mutant allele) suggests that homozygotes do not produce one or more disease-protective peptides.
The KLRC4 Behçet's disease-associated SNP ( Table 1) is within a haplotype block containing five natural killer (NK) cell receptor genes (KLRK1, KLRC1, KLRC2, KLRC3 and KLRC4) (Fig. 2c) . Two nonsynonymous variants in KLRC4, rs1841958 and rs2617170, encoding KLRC4 p.Ile29Ser and p.Asn104Ser alterations, respectively, are found on the Behçet's disease protective haplotype of this LD block. This haplotype has been associated with reduced peripheral blood leukocyte cytotoxicity and increased incidence of cancer 27 . Conditional logistic regression analysis, conditioning on the variant encoding KLRC4 p.Asn104Ser, showed no additional independent association signals within this LD block (Supplementary Fig. 1a) . KLRC4, also called NKG2F, encodes a C-type lectin receptor whose function is largely unknown. A possible clue to its function may be l e t t e r s A1, allele 1; A2, allele 2; TOF-MS, time-of-flight mass spectrometry; MAF, minor allele frequency. Japanese samples were not included in the meta-analysis of the rs17810546 (IL12A) and rs17482078 (ERAP1) variants because they are not polymorphic or they showed too low of a frequency in the Japanese population. Combined data with genome-wide significance are shown in bold.
npg l e t t e r s found in a related protein, NKG2D, encoded by KLRK1 that is also located within the disease-associated haplotype block. NKG2D is expressed on NK cells and γδ T cells and can act as a costimulatory molecule for CD4 + and CD8 + T cells 28, 29 . Notably, a ligand of the NKG2D receptor is MICA (MHC class I chain-related protein A) 28 . The MICA gene is located within the MHC region, and SNPs within the MICA locus are in LD with HLA-B*51 (ref. 6 ). The importance of NK receptors in Behçet's disease pathogenesis is also supported by the observation that the strongest linkage peak in Turkish familial Behçet's disease (logarithm of odds (LOD) score of 3.94) is found on chromosome 12p12-13, which includes the KLRK locus 30 .
The disease-associated variants in the 3′ flanking region of CCR1-CCR3 (rs7616215) and within intron 3 of STAT4 (rs7574070) are noncoding and are not in strong LD with any coding variants (Fig. 2a,b) . The CCR1-CCR3 locus contains a cluster of chemokine receptor genes within the LD block. Logistic regression analysis conditioning on rs7616215 as a covariate identified only a single association signal in the region (Supplementary Fig. 1b) . Encyclopedia of DNA Elements (ENCODE) data indicated that rs7616215 and rs7574070 are located within DNase I hypersensitivity and histone 3 lysine 4 methylation sites, suggesting effects on transcription.
Indeed, CCR1 mRNA expression was higher in primary human than in donors without the C allele monocytes from healthy donors with the disease protective C allele (P = 9.5 × 10 −6 (Zeller et al. 31 ); Fig. 4a ; P = 0.017; Fig. 4b) . The Behçet's disease-associated variant was not, however, found to be associated with the expression of the nearby gene CCR3 (ref. 31) . Concordant with the expression data, the migration of monocytes in response to a gradient of the CCR1 ligand MIP1-α was higher in individuals with the C allele than in individuals without it (P = 0.015; Fig. 4c) . Comparison of CCR1 mRNA expression levels with the migration index in matched samples (n = 34) showed significant correlation (Spearman's ρ = 0.46, P = 0.007; Fig. 4d) . Thus, CCR1 expression and monocyte chemotaxis were reduced in individuals with the disease risk allele, suggesting that impaired clearance of pathogens may contribute to Behçet's disease pathogenesis. Future experiments will be required to further elucidate the importance of the observed differences.
STAT4 mRNA expression was higher in individuals with the A risk allele than in individuals without it (Fig. 4e,f) . The Behçet's diseaseassociated variant rs7574070 (and its surrogate rs7572482) is in poor LD with the previously reported autoimmune disease-associated STAT4 variant rs7574865 (ref. 32); in fact, it is located two LD blocks away, suggesting that the associations are independent, although both variants are located within the large intron 3 of STAT4 (Fig. 2b) . Both variants are associated with increased expression of STAT4 (Fig. 4e, npg l e t t e r s different STAT4 regulatory mechanisms in Behçet's disease compared with rheumatoid arthritis, systemic lupus erythematosus and other autoimmune diseases. The smaller effect sizes observed for the associations of the CCR1 and STAT4 variants in the Japanese replication ( Table 1) could be explained by 'winner's curse' (ref. 34 ).
In conclusion, we report new susceptibility loci for Behçet's disease at CCR1-CCR3, STAT4, KLRK1-KLRC4 and ERAP1. Furthermore, the results support an emerging concept delineating common pathogenic mechanisms for Behçet's disease and two spondyloarthropathy diseases, ankylosing spondylitis and psoriasis. All three of these diseases are inflammatory disorders affecting the skin, eyes and joints, with significant MHC class I associations (HLA-B*51 for Behçet's disease, HLA-B*27 for ankylosing spondylitis and HLA-C*06 for psoriasis). Recent genetic studies implicate variants of IL23R, encoding an upstream molecule involved in the activation of the T H 17 subset of helper T cells, in susceptibility to all three disorders. The present work adds ERAP1 to the list of shared genetic factors, and, furthermore, interactions between the MHC class I region and ERAP1 are also found in all three of these diseases. ERAP1 trims peptides for proper loading onto MHC class I antigens, thus suggesting that peptide-MHC class I interactions contribute to all three diseases. These genetic data suggest the existence of shared inflammatory pathways in Behçet's disease, ankylosing spondylitis and psoriasis, leading to the possibility of common therapeutic strategies, while raising questions about specific disease characteristics, which may be related to their different MHC class I associations.
oNLINE METHodS
Study subjects. We studied 1,215 Turkish Behçet's disease cases and 1,278 genetically matched controls used in previous GWAS 6 . Individuals who also met the Tel-Hashomer clinical criteria for diagnosis with familial Mediterranean fever (FMF) 35 were excluded (n = 6). For replication, we included additional, similarly collected 838 Turkish cases (none of whom fulfilled FMF criteria) and 630 controls and 612 Japanese Behçet's disease cases and 740 control samples enrolled in a previous GWAS 7 . Turkish individuals with Behçet's disease fulfilled the International Study Group diagnostic criteria for Behçet's disease 19 . All Japanese individuals with Behçet's disease fulfilled the Japanese Behçet's disease diagnostic criteria 7 , and 496 of them also fulfilled the International Study Group criteria. All study participants provided written informed consent, and the study was approved by the ethics committee of each investigative institution.
Genotype imputation. We imputed the genotypes of 1,209 Behçet's disease cases and 1,278 controls using MACH v1.0. For a reference panel, we used 96 healthy Turkish controls who participated in the previous Behçet's disease GWAS using the HumanHap370CNV chip (Illumina) and additionally genotyped on the Human OMNI 1M chip (Illumina). For quality control, we excluded SNPs from the reference panel if they had a minor allele frequency less than 5%, deviated from Hardy-Weinberg equilibrium (P < 0.0001) or had a call rate below 95%, yielding 814,474 SNPs for the imputation. Quality scores for the imputation are shown in Supplementary Table 6 . SNPs with Rsq < 0.3 were excluded from the association analysis. A total of 779,465 imputed SNPs were included in the genome-wide association analysis.
Validation and fine mapping. The Turkish GWAS imputation provided the discovery data. Twenty-two SNPs from the newly associated genetic loci were selected for evaluation in the Turkish replication samples. Three of these SNPs with association at P < 0.001 and one SNP from the phenotypic subset analysis identified four regions for validation and fine mapping by iPLEX assays (TOF-MS, Sequenom) using the original Turkish GWAS samples 6 . The IL12A locus with two SNPs associated at P < 0.05 in the replication samples was also investigated but did not reach genome-wide significance. For variants that had unsuccessful TOF-MS design or reaction, TaqMan genotyping was performed (Applied Biosystems). Genotyping was performed in an unbiased fashion by masking the phenotype of the samples. For the fine mapping, we used the Tagger SNP selection tool from HapMap to select SNPs to augment the coverage of the GWAS SNPs with the intent of obtaining 100% coverage of the HapMap phase 3 SNPs with greater than 5% minor allele frequency in the CEU HapMap population with pairwise r 2 > 0.8. Although already tagged, additional SNPs with r 2 > 0.8 with the most significantly associated SNP of the region were also included. Genotyping of the same samples used for the Turkish GWAS discovery collection was performed 6 . After quality control, the resulting coverage for the CCR1 locus (chr. 3: 45,441,901-46,908,964, hg18) was 92%, the STAT4 locus (chr. 2: 191,602,386-191,769,025) was 84%, the KLRK1-KLRC1 locus (chr. 12: 10,329,925-10,557,292) was 92% and the ERAP1-ERAP2 locus (chr. 5: 96,026,703-96,305,246) was 94%. The most significantly associated marker from each region was used for replication. Japanese replication collection genotypes were from a Japanese GWAS 7 . The Turkish replication collection samples were genotyped by TOF-MS or TaqMan assay. mRNA expression data and migration assays. CCR1 mRNA expression data were extracted from the report by Zeller and colleagues, which includes genome-wide SNP data along with mRNA expression array data from the monocytes of 1,490 individuals of European ancestry 31 . The rs7616215 SNP showed association with CCR1 mRNA expression (P = 9.54 × 10 −6 ), whereas CCR3 data were not reported, indicating that the association of rs7616215 with CCR3 is less significant (P > 5 × 10 −5 ). STAT4 mRNA expression data in lymphoblastoid samples were obtained from GEO data sets 36, 37 . Primary human monocytes from unrelated healthy volunteers were isolated from peripheral blood mononuclear cells using the MACS Human Monocyte Isolation kit (Miltenyi Biotec). RNA was isolated from peripheral blood mononuclear cells using the RNeasy kit (Qiagen) and preserved at −80 °C until used. cDNA was prepared from RNA pretreated with DNase I (Invitrogen) using SuperScript II according to the manufacturer's protocol (Invitrogen). The quantitative PCR gene expression assay for human CCR1 (Hs00174298_m1) was purchased from Applied Biosystems. Human GAPDH (4310884E) served as an internal control. Multiplex PCR (GAPDH with CCR1) was performed in triplicate or quadruplicate, as described in the manufacturer's protocol (Applied Biosystems). The ∆∆C T method was used for the analysis (n = 93).
Monocyte migration assays were performed with 24-well Transwell 5-µm polycarbonate membrane chambers (Costar). We used RPMI 1640 medium supplemented with 1% BSA for incubation of the cells. Cells (5 × 10 4 ) were seeded in the upper chamber, and the CCR1 chemokine MIP1-α (0 or 10 ng/ml) (R&D Systems) was placed in the lower chamber. After incubation for 2 h, cells that migrated into the membrane were fixed and stained by DiffQuik (Siemens). Cells were counted in five high-power fields on membranes from each of two duplicate wells. The relative change in cell migration in response to the chemokine was determined by dividing the migrated cell count obtained with MIP1-α by the cell count obtained from the same sample without MIP1-α (n = 61).
Statistical analysis. Genome-wide SNP association tests were performed on the basis of allelic tests by comparing the allele frequencies between Behçet's disease cases and controls using Golden Helix SVS 7.5.2 software. P < 5 × 10 −8 was considered to represent genome-wide significance. For the uveitis subset analysis, as well as the basic allelic test, we applied dominant and recessive genetic model tests and therefore set P < 1.67 × 10 −8 as genome-wide significance. Conditional analyses were performed by fitting the logistic regression model with rs2617170 (for KLRK1-KLRC1) or rs7616215 (for CCR1-CCR3) as covariates. For meta-analysis, Cochran-Mantel-Haenszel tests were performed. To test for interactive effects, we fitted the log likelihood of the full model, including additive terms of the main effects and a multiplicative term of the interaction effect, versus a reduced model of the additive terms of the main effects only. P values were calculated by likelihood ratio tests between full and reduced models on the basis of 1-degree-of-freedom χ-square test statistics. For comparisons in expression and chemotaxis data, the Kruskal-Wallis ranksum test as a non-parametric version of one-way ANOVA and the Spearman's rank correlation test were performed.
